Cancer
Credibility 80
Dual-modal immunoassay for prostate cancer-derived exosomes enabled by a black phosphorus/silver SERS substrate and Yb/Er co-doped NaGdF4 UCL nanoprobes.
February 1, 2027 · Talanta
Key takeaway
New research developed a better way to find prostate cancer early by detecting tiny particles from cancer cells. This could lead to quicker, more accurate screening tests, which is crucial for Black men who face higher risks and poorer outcomes if prostate cancer isn't caught soon.
Why this matters for our communities
Research in cancer helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Cancer
December 18, 2026Factors Associated with Screening Mammography Utilization Among Women Veterans in VA Primary Care.Read November 16, 2026Characterizing prior symptomatic emergency department visits among patients undergoing unplanned colon cancer surgery.Read November 15, 2026Can Engagement Aid in Design and Accrual on Clinical Trials? Observations from Comparative Study of Proton and Photon Therapy in Prostate Cancer: A Prospective Comparison of Outcomes with Proton and Photon Radiation in Prostate Cancer.Read